Bank of America’s Mural Oncology MURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-262
Closed -$542 8031
2025
Q3
$542 Sell
262
-207
-44% -$445 ﹤0.01% 7575
2025
Q2
$1.16K Buy
469
+49
+12% +$115 ﹤0.01% 7508
2025
Q1
$529 Sell
420
-78
-16% -$284 ﹤0.01% 7509
2024
Q4
$1.6K Sell
498
-661
-57% -$2.33K ﹤0.01% 7225
2024
Q3
$3.63K Sell
1,159
-177
-13% -$576 ﹤0.01% 7061
2024
Q2
$4.2K Sell
1,336
-4,342
-76% -$16K ﹤0.01% 7044
2024
Q1
$27.8K Sell
5,678
-10,750
-65% -$52.2K ﹤0.01% 6682
2023
Q4
$97.3K Buy
+16,428
New +$66.1K ﹤0.01% 6384

Bank of America's MURA Position: Q4 2025 in Review

Bank of America sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 262 shares — an estimated $542 sold.

Bank of America first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $97.3K in Q4 2023. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

  • Bank of America reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
  • Bank of America sold 262 Mural Oncology shares in Q4 2025, an estimated $542.
  • Bank of America first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
  • Bank of America's Mural Oncology position peaked at $97.3K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Bank of America's 13F filing for Q4 2025, filed 17 Feb 2026.